What is Liver Cancer?

• Hepatocellular carcinoma (HCC) is the most common form of liver cancer.
• Primarily caused by chronic hepatitis B (HBV) and hepatitis C (HCV) infections.
• Hepatitis B leads to liver cirrhosis, increasing the risk of liver cancer.

Hepatitis B Vaccine

• Highly effective in preventing hepatitis B infection.
• Reduces the risk of liver cancer by preventing chronic hepatitis B.
• Administered in three to four doses starting at birth.

Hepatitis C and Prevention

• No vaccine for hepatitis C, but antiviral treatments can cure infections.
• Treatment reduces the long-term risk of liver cancer.
• Efforts to develop a hepatitis C vaccine are ongoing.

Impact of Vaccination Programs

• Hepatitis B vaccination programs have significantly lowered liver cancer rates.
• Countries like Taiwan and South Korea show dramatic declines in liver cancer due to vaccination.
• The WHO aims to eliminate hepatitis B as a public health problem by 2030.

Combining Vaccination and Screening

• Routine screening is essential for individuals with chronic hepatitis B or C infections.
• Ultrasound and AFP blood tests can detect liver cancer early.
• Vaccination protects against hepatitis B, but screening remains crucial for liver health.

Challenges in Hepatitis B Vaccination

• Access to vaccines, healthcare infrastructure, and public awareness remain challenges in low-income regions.
• Global organizations are working to increase vaccination efforts, especially in high-risk areas.

Conclusion

• Hepatitis B vaccine plays a crucial role in preventing liver cancer.
• Global vaccination efforts and early screening are key to reducing liver cancer rates.
• Continued research and access to treatment can help in the fight against liver cancer.